WG Non-Surgical Ablative Therapy of Benign Uterine Disease Chair:

H. Verhoeven

WG Non-Surgical Ablative Therapy of Benign Uterine Disease Vice Chair:

R.L. De Wilde

WG Non-Surgical Ablative Therapy of Benign Uterine Disease Members:

S. Becker, R. Devassy, F. Gill, A. Pessarrodona Isern, V. Tanos

WG Non-Surgical Ablative Therapy of Benign Uterine Disease Guest Members:

J. Rodriguez Gonzalez, J. Huber, A. Carmona Ruiz

WG Non-Surgical Ablative Therapy of Benign Uterine Disease Projects:

Goal: Scientific evaluation of clinical efficacy and complications of non-surgical ablative therapy in Europe

Activities 2021:

- The WoGr was active especially outside of Europe. Lectures on minimal or non-invasive treatment of benign disease of the uterine wall in Africa and South America, Europe and the Middle East
- Prof De Wilde worked on associations with the International Society of Minimally Invasive and Virtual Surgery and MESGE
- The WoGr under the guidance of Prof De Wilde published 2 papers in international journals